RFK Jr. and other Trump officials embrace psychedelics after FDA setback
A presidential administration finally seems to agree.
"This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months," Health Secretary Robert F.
Kennedy
Jr. recently told members of Congress.
His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs. And it comes as psychedelics are making inroads in deep red states like Texas, where former
Trump
cabinet secretary and ex-governor Rick Perry has thrown his full support behind the effort.
The administration's embrace of psychedelics has sparked both excitement as well as concern from those in the field, who worry the drugs might be discredited if they appear to be rushed onto the market or are too closely linked with Kennedy, who is known for controversial views on vaccines, antidepressants and fluoride.
"I'm quite optimistic," says Rick Doblin, whose organization has pursued the medical use of MDMA (or ecstasy) since the 1980s. "But I'm also worried that the message the public might get is 'Well,
RFK
likes psychedelics and now it's approved.'"
FDA
may reconsider MDMA Under President Joe Biden, the FDA rejected MDMA as a treatment for post-traumatic stress disorder, citing flawed data and questionable research. Regulators called for a new study, likely taking several years. It was a major setback for Doblin and other advocates hoping to see the first U.S. approval of a psychedelic for medical use.
But the agency appears ready to reconsider. FDA chief Marty Makary, who reports to Kennedy, has called the evaluation of MDMA and other psychedelics "a top priority," announcing a slate of initiatives that could be used to accelerate their approval.
One new program promises to expedite drugs that serve "the health interests of Americans," by slashing their review time from six months or more to as little as one month. Makary has also suggested greater flexibility on requirements for certain drugs, potentially waiving rigorous controlled studies that compare patients to a placebo group.
That approach, considered essential for high-quality research, has long been a stumbling point for psychedelic studies, in which patients can almost always correctly guess whether they've received the drug or a dummy pill.
The U.S. Department of Health and Human Services and FDA also recently hired several new staffers with ties to the psychedelic movement.
"These are all very promising signs that the administration is aware of the potential of psychedelics and is trying to make overtures that they're ready to approve them," said Greg Ferenstein, a fellow at the libertarian Reason Foundation, who also consults for psychedelic companies. "We didn't hear anything about that in the Biden administration"
A spokesperson for HHS did not respond to a request for comment.
As a presidential candidate, Kennedy discussed how his son and several close friends benefited from using psychedelics to deal with grief and other issues.
A number of veterans lobbying for psychedelic access have already met with Trump's Secretary of Veterans Affairs, Doug Collins.
"What we're seeing so far is positive," Collins told House lawmakers in May.
But some experts worry the hope and hype surrounding psychedelics has gotten ahead of the science.
Philip Corlett, a psychiatric researcher at Yale University, says bypassing rigorous clinical trials could set back the field and jeopardize patients.
"If RFK and the new administration are serious about this work, there are things they could do to shepherd it into reality by meeting the benchmarks of medical science," Corlett said. "I just don't think that's going to happen."
Texas goes all-in on ibogaine research As officials in Washington weigh the future of psychedelics, some states are moving ahead with their own projects in hopes of nudging the federal government. Oregon and Colorado have legalized psychedelic therapy.
And last month, Texas approved $50 million to study ibogaine, a potent psychedelic made from a shrub that's native to West Africa, as a treatment for opioid addiction, PTSD and other conditions. The research grant - the largest of its kind by any government - passed with support from the state's former GOP governor, Perry, and combat veterans, some who have traveled to clinics in Mexico that offer ibogaine.
Ibogaine is on the U.S. government's ultra-restrictive list of illegal, Schedule 1 drugs, which also includes heroin. So advocates in Texas are hoping to build a national movement to ease restrictions on researching its use.
"Governmental systems move slowly and inefficiently," said Bryan Hubbard of Americans for Ibogaine, a group formed with Perry. "Sometimes you find yourself constrained in terms of the progress you can make from within."
Ibogaine is unique among psychedelics in both its purported benefits and risks. Small studies and anecdotal reports suggest the drug may be able to dramatically ease addiction and trauma. It was sold for medical use in France for several decades starting in the 1930s, but the drug can also cause dangerous irregular heart rhythms, which can be fatal if left untreated.
Some veterans who have taken the drug say the risks can be managed and ibogaine's healing properties go far beyond antidepressants, mood stabilizers, counseling and other standard treatments.
Marcus Capone struggled with anger, insomnia and mood swings after 13 years as a Navy Seal. In 2017, at the urging of his wife Amber, he agreed to try ibogaine as a last resort. He described his first ibogaine session as "a complete purge of everything."
"But afterward I felt the weight just completely off my shoulders," he said. "No more anxiety, no more depression, life made sense all of a sudden."
A nonprofit founded by the Capones, Veterans Exploring Treatment Solutions, or VETS, has helped over 1,000 veterans travel abroad to receive ibogaine and other psychedelics.
But federal scientists have looked at the drug before - three decades ago, when the National Institute on Drug Abuse funded preliminary studies on using it as an addiction treatment. The research was discontinued after it identified "cardiovascular toxicity."
"It would be dead in the water," in terms of winning FDA approval, longtime NIDA director Nora
Volkow
said.
But Volkow said her agency remains interested in psychedelics, including ibogaine, and is funding an American drugmaker that's working to develop a safer, synthetic version of the drug.
"I am very intrigued by their pharmacological properties and how they are influencing the brain," Volkow said. "But you also have to be very mindful not to fall into the hype and to be objective and rigorous in evaluating them."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
9 minutes ago
- Business Standard
US fertility rate reached new low in 2024 with 1.6 kids per woman: CDC
The fertility rate in the US dropped to an all-time low in 2024 with less than 1.6 kids per woman, new federal data released Thursday shows. The US was once among only a few developed countries with a rate that ensured each generation had enough children to replace itself about 2.1 kids per woman. But it has been sliding in America for close to two decades as more women are waiting longer to have children or never taking that step at all. The new statistic is on par with fertility rates in western European countries, according to World Bank data. Alarmed by recent drops, the Trump administration has taken steps to increase falling birth rates, like issuing an executive order meant to expand access to and reduce costs of in vitro fertilisation and backing the idea of baby bonuses that might encourage more couples to have kids. But there's no reason to be alarmed, according to Leslie Root, a University of Colorado Boulder researcher focused on fertility and population policy. We're seeing this as part of an ongoing process of fertility delay. We know that the US population is still growing, and we still have a natural increase more births than deaths, she said. The US Centers for Disease Control and Prevention released the statistic for the total fertility rate with updated birth data for 2024. In the early 1960s, the US total fertility rate was around 3.5, but plummeted to 1.7 by 1976 after the Baby Boom ended. It gradually rose to 2.1 in 2007 before falling again, aside from a 2014 uptick. The rate in 2023 was 1.621, and inched down in 2024 to 1.599, according to the CDC's National Center for Health Statistics. Birth rates are generally declining for women in most age groups and that doesn't seem likely to change in the near future, said Karen Guzzo, director of the Carolina Population Center at the University of North Carolina. People are marrying later and also worried about their ability to have the money, health insurance and other resources needed to raise children in a stable environment. Worry is not a good moment to have kids, and that's why birth rates in most age groups are not improving, she said. Asked about birth-promoting measures outlined by the Trump administration, Guzzo said they don't tackle larger needs like parental leave and affordable child care. The things that they are doing are really symbolic and not likely to budge things for real Americans, she said. Increase in births in new data The CDC's new report, which is based on a more complete review of birth certificates than provisional data released earlier this year, also showed a 1 per cent increase in births about 33,000 more last year compared to the prior year. That brought the yearly national total to just over 3.6 million babies born. But this is different: The provisional data indicated birth rate increases last year for women in their late 20s and 30s. However, the new report found birth rate declines for women in their 20s and early 30s, and no change for women in their late 30s. What happened? CDC officials said it was due to recalculations stemming from a change in the US Census population estimates used to compute the birth rate. That's plausible, Root said. As the total population of women of childbearing age grew due to immigration, it offset small increases in births to women in those age groups, she said. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
New Indian Express
9 minutes ago
- New Indian Express
'World sleeps; while it is awake, its conscience is buried': Chidambaram on Gaza humanitarian crisis
NEW DELHI: Senior Congress leader and former Finance Minister P Chidambaram on Thursday raised concerns on the humanitarian crisis in Gaza and said that every day, the number of killings in the region is in the double digits, with many of them being women and children. In a post on X, Chidambaram said, "Humanity is shamed in Gaza every day, the number of killings in Gaza is in the double-digits. Many of them are women and children who had nothing to do with starting the conflict." He said that 1000 Palestinians have been killed in Gaza while trying to get food. "According to the UN, over 1000 Palestinians have been killed since May while trying to get food in the Gaza Strip Look at the pictures of hungry children at refugee camps. It is obvious they are starving -- and dying," Chidambaram said. "The world sleeps; while it is awake, its conscience is buried," he said. Earlier, India called for immediate ceasefire in Gaza, uninterrupted humanitarian aid and release of hostages to address the deepening crisis in the region. Speaking at the United Nations Security Council's quarterly open debate on the Middle East, India's Permanent Representative to the United Nations, Ambassador Parvathaneni Harish, said that mere pauses in hostilities are not enough to address the worsening humanitarian situation. "Intermittent pauses in hostilities are not enough to address the scale of humanitarian challenges confronting the people, who grapple daily with acute shortages of food and fuel, inadequate medical services and lack of access to education," he said. Harish expressed concern over the collapsing healthcare and education systems in Gaza. "WHO estimates that around 95 percent of all hospitals in Gaza are damaged or destroyed. The Office of the High Commissioner for Human Rights reports that more than 6,50,000 children have had no schooling for over 20 months," he said. Israel's war on Gaza, since Oct. 7, 2023, has now killed at least 58,386 people and wounded 139,077, mostly women and children, according to the Gaza Health Ministry's data.
Economic Times
37 minutes ago
- Economic Times
The US fertility rate reached a new low in 2024, CDC data shows
Synopsis U.S. fertility rate hits a record low of 1.6 children per woman in 2024, raising concerns after previously maintaining replacement levels. Despite Trump administration's efforts to boost birth rates, experts like Leslie Root suggest it's a fertility delay, noting continued population growth. CDC data reveals a 1% birth increase, totaling 3. AP FILE - The toes of a baby are seen at a hospital in McAllen, Texas, on Wednesday, July 29, 2020. (AP Photo/Eric Gay, File) The fertility rate in the U.S. dropped to an all-time low in 2024 with less than 1.6 kids per woman, new federal data released Thursday shows. The U.S. was once among only a few developed countries with a rate that ensured each generation had enough children to replace itself - about 2.1 kids per woman. But it has been sliding in America for close to two decades as more women are waiting longer to have children or never taking that step at all. The new statistic is on par with fertility rates in western European countries, according to World Bank data. Alarmed by recent drops, the Trump administration has taken steps to increase falling birth rates, like issuing an executive order meant to expand access to and reduce costs of in vitro fertilization and backing the idea of "baby bonuses" that might encourage more couples to have kids. But there's no reason to be alarmed, according to Leslie Root, a University of Colorado Boulder researcher focused on fertility and population policy. "We're seeing this as part of an ongoing process of fertility delay. We know that the U.S. population is still growing, and we still have a natural increase - more births than deaths," she said. The U.S. Centers for Disease Control and Prevention released the statistic for the total fertility rate with updated birth data for 2024. In the early 1960s, the U.S. total fertility rate was around 3.5, but plummeted to 1.7 by 1976 after the Baby Boom ended. It gradually rose to 2.1 in 2007 before falling again, aside from a 2014 uptick. The rate in 2023 was 1.621, and inched down in 2024 to 1.599, according to the CDC's National Center for Health Statistics. Birth rates are generally declining for women in most age groups - and that doesn't seem likely to change in the near future, said Karen Guzzo, director of the Carolina Population Center at the University of North Carolina. People are marrying later and also worried about their ability to have the money, health insurance and other resources needed to raise children in a stable environment. "Worry is not a good moment to have kids," and that's why birth rates in most age groups are not improving, she said. Asked about birth-promoting measures outlined by the Trump administration, Guzzo said they don't tackle larger needs like parental leave and affordable child care. "The things that they are doing are really symbolic and not likely to budge things for real Americans," she said. Increase in births in new data The CDC's new report, which is based on a more complete review of birth certificates than provisional data released earlier this year, also showed a 1% increase in births - about 33,000 more - last year compared to the prior year. That brought the yearly national total to just over 3.6 million babies born. But this is different: The provisional data indicated birth rate increases last year for women in their late 20s and 30s. However, the new report found birth rate declines for women in their 20s and early 30s, and no change for women in their late 30s. What happened? CDC officials said it was due to recalculations stemming from a change in the U.S. Census population estimates used to compute the birth rate. That's plausible, Root said. As the total population of women of childbearing age grew due to immigration, it offset small increases in births to women in those age groups, she said.
